Chemoinformaics analysis of 1-HYDROXY-2,3,4,5-TETRAMETHOXYXANTHEN-9-ONE
| Molecular Weight | 332.308 | nRot | 4 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 17 |
| Exact Molecular Weight | 332.09 | nRing | 3 |
| Solubility: LogS | -3.778 | nHRing | 1 |
| Solubility: LogP | 2.496 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 44.6727 |
| nHD | 1 | BPOL | 25.5993 |
| QED | 0.735 |
| Synth | 2.477 |
| Natural Product Likeliness | 1.221 |
| NR-PPAR-gamma | 0.447 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.991 |
| Pgp-sub | 0 |
| HIA | 0.02 |
| CACO-2 | -4.731 |
| MDCK | 0.0000305 |
| BBB | 0.051 |
| PPB | 0.738343 |
| VDSS | 1.097 |
| FU | 0.278568 |
| CYP1A2-inh | 0.489 |
| CYP1A2-sub | 0.985 |
| CYP2c19-inh | 0.316 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.619 |
| CYP2c9-sub | 0.874 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.609 |
| CYP3a4-inh | 0.366 |
| CYP3a4-sub | 0.557 |
| CL | 3.575 |
| T12 | 0.662 |
| hERG | 0.013 |
| Ames | 0.542 |
| ROA | 0.796 |
| SkinSen | 0.669 |
| Carcinogencity | 0.254 |
| EI | 0.224 |
| Respiratory | 0.253 |
| NR-Aromatase | 0.877 |
| Antiviral | Yes |
| Prediction | 0.722619 |